Simple blood test could spot osteoarthritis years earlier

NCT ID NCT07544823

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study aims to find blood-based biomarkers that can diagnose osteoarthritis (OA) earlier than current methods. Researchers will collect blood samples from 300 people aged 40-70 with joint pain to test previously identified candidate markers. The goal is to develop a simple, reliable blood test for early OA detection, potentially enabling earlier treatment and reducing long-term disability.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this could lead to a simple blood test for early osteoarthritis detection, allowing for earlier intervention and better management.

What could go wrong

This is an observational study, not a treatment trial. The biomarkers identified may not prove reliable in larger, more diverse populations.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OSTEOARTHRITIS (OA) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

osteoarthritis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • The First Affiliated Hospital of Henan Medical University

    RECRUITING

    Xinxiang, Henan, 453003, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••